-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師總結如下：OLED第一季業績表現不佳，營收年減14.5%至1.42億美元，遠低於市場普遍預期（1.61億美元）；每股收益為0.76美元，年減44%，低於華爾街預期（1.20美元）。業績疲軟主要體現在各方面，材料銷售額下降2.9%至8,400萬美元，特許權使用費/許可費下降26.4%至5,400萬美元，是拖累季度業績的主要因素。管理階層將2026年營收預期從先前的6.75億美元下調至6.5億美元，理由是市場需求疲軟。財務長指出，短期市場狀況趨於穩定，但對長期成長前景仍充滿信心，包括韓國和中國預計今年投產的8.6代新增產能。我們認同管理階層對長期前景的樂觀態度，但注意到當前疲軟的市場環境可能會延緩新建OLED工廠的產能爬坡進程。我們認為，鑑於市場環境依然動盪，經修訂的第二季至第四季業績預期（5.08億美元）存在低於公司預期的下行風險。
Related Articles
Asia
Collins Foods Confirms Partnership Arrangement Condition Met for Taco Bell Transition
Collins Foods (ASX:CKF) said conditions precedent for the transition of 20 Taco Bell restaurants to a new partnership arrangement between an affiliated company of Taco Bell and Restaurant Brands Australia have been satisfied, according to a Friday Australian bourse filing.The company said the transaction remains subject to other customary conditions, including landlord consents, a store-based employment threshold, and Australian Competition and Consumer Commission (ACCC) clearance, with completion expected between June and August, depending on regulatory approval timelines.
$ASX:CKF
Asia
NZX Q1 Revenue Rises 5%
NZX (NZE:NZX) reported first-quarter revenue of NZ$32.7 million, up 5% from NZ$31.1 million in the year-ago period, according to a Friday filing on the bourse.The number of total listed securities on the exchange as of March 31 fell 1.8% year over year to 323, per the filing.
$NZE:NZX
Asia
Avita Medical Appoints CEO, Chair
Avita Medical (ASX:AVH) has appointed Cary Vance as chief executive, effective immediately, according to a Friday Australian bourse filing.Vance has been acting as interim CEO since October 2025, per the filing.The company also appointed Jan Stern Reed as chair with immediate effect, the filing added.
$ASX:AVH